Patent · US Active

Crystalline forms of (S)-afoxolaner

US11130739B2 · kind B2 · utility

0Cited by
2References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 20, 2020
Grant dateSep 28, 2021
Priority date
Expiry dateMar 20, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides crystalline forms of compound of formula (Ia) and processes of making the crystalline forms. Also provided are compositions comprising the crystalline forms and methods of use of the crystalline forms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.